Conclusions: These findings indicate that follistatin may act as an inhibitory regulator of PAI-1 expression in individuals with MASLD and obesity, potentially contributing to reductions in the prothrombotic status during dietary intervention. Here, SERPINE1 is linked to obesity due to melanocortin 4 receptor deficiency.